Gil Yong Park

Dr. Gil Yong Park

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GPGil Yong Park
Gil Yong Park
AJAngelo Jamerlan
Angelo Jamerlan
KSKyu Hwan Shim
Kyu Hwan Shim
Seong AnSeong An
Seong An
Transthyretin (TTR) is a thyroid hormone-binding protein which transports thyroxine from the bloodstream to the brain. The structural stability of TTR in tetrameric form is crucial for maintaining its original functions in blood or cerebrospinal fluid (CSF). The altered structure of TTR due to genetic mutations or its deposits due to aggregation could cause several deadly diseases such as cardiomyopathy and neuropathy in autonomic, motor, and sensory systems. The early diagnoses for hereditary amyloid TTR with cardiomyopathy (ATTR-CM) and wild-type amyloid TTR (ATTRwt) amyloidosis, which result from amyloid TTR (ATTR) deposition, are difficult to distinguish due to the close similarities of symptoms. Thus, many researchers investigated the role of ATTR as a biomarker, especially its potential for differential diagnosis due to its varying pathogenic involvement in hereditary ATTR-CM and ATTRwt amyloidosis. As a result, the detection of ATTR became valuable in the diagnosis and determination of the best course of treatment for ATTR amyloidoses. Assessing the extent of ATTR deposition and genetic analysis could help in determining disease progression, and thus survival rate could be improved following the determination of the appropriate course of treatment for the patient. Here, the perspectives of ATTR in various diseases were presented.

1 March 2018 in Reactive and Functional Polymers
Verified
Journal Article
Closed access
CLChaeyeon Lee
Chaeyeon Lee
JCJi Eun Choi
Ji Eun Choi
GPGil Yong Park
Gil Yong Park
TLTaeheon Lee
Taeheon Lee
JKJinku Kim
Jinku Kim
HPHyun-jong Paik
Hyun-jong Paik